On lighter skin, plaque psoriasis can appear red; on darker skin, it can be purple or grayish. It often goes underdiagnosed and undertreated in the Black community, so it’s important to know ...

Studies involving multiple aspects of plaque psoriasis evolution, persistence, and progression have produced clues and ...

but on darker skin types, psoriasis may look dark brown or violet with grayish scales," she adds. Why confidence is key for ...

“Inflammatory skin conditions like psoriasis may appear different in Black patients,” Dr. Rodney says. “While psoriasis appears as red, scaly plaques in light skin, you may only see brown pl ...

Clinical efficacy was evaluated using the Psoriasis Area and Severity Index (PASI), along with metabolic indicators such as ...

Icotrokinra appears to be an effective treatment for adolescents with moderate to severe plaque psoriasis, according to a subgroup analysis of the ICONIC-LEAD study.

Substantial savings opportunities exist by using lower-cost biologics for patients with plaque psoriasis, according to one ...

Icotrokinra achieved 75% complete skin clearance in adolescents with moderate to severe plaque psoriasis by week 24, indicating significant efficacy. The ICONIC-LEAD trial is the first to evaluate ...

In the Phase III ICONIC-LEAD trial, 75% of adolescents with moderate-to-severe plaque psoriasis treated with icotrokinra achieved completely clear skin by week 24. Results from the Phase III ...

Deucravacitinib has been observed as a safe and efficacious treatment for adults with moderate to severe plaque psoriasis for up to 4 years.

Icotrokinra is efficacious and safe for treating moderate to severe plaque psoriasis among adolescents and adults when compared with placebo.

References: Icotrokinra results show 75% of adolescents with plaque psoriasis achieved completely clear skin and demonstrate favorable safety profile in a once daily pill. News release.